Régis brings more than 25 years of experience in the areas of finance, structuring and management of health technology companies. Prior to joining Tridek-One, Régis was CEO of Axess Vision Technology, a company dedicated to the development of single-use medical endoscopes, where he led the launch of new products and
Olivier is an accomplished antibody engineer with more than 30-year experience having worked for biotech (MRC collaborative centre and NovImmune) and pharma companies (Pierre Fabre, Merck Serono and Vetoquinol). Co-inventor of three marketed therapeutic antibodies, Tysarbri, Bavencio and Gamifant. Co-founder of the technology company Deeptope. Olivier has expertise in antibody
Jean-François has been working in the field of immunology for 30-yr + including 20 years for several biotech and pharmaceutical companies (Serono Pharmaceutical, Merck Serono SA, Merck KGaA, Fresenius-Kabi, and GeNeuro SA). He has expertise in the development of biologics for FiM readiness including selection of PoC studies to serve autoimmune,
Laurence is a seasoned pharma/biotech professional with over 25 years of experience in transactions and R&D operations and general management. She has worked in VC funded biotech start-ups, mid-size private companies as well as large corporate organizations. Prior to joining Tridek-One, Laurence was COO and CBO of AMAL Therapeutics, a